Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors
ClinicalTrials.gov study NCT04569916. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
ClinicalTrials.gov study NCT05193188. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC
ClinicalTrials.gov study NCT03987867. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT05368051. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies
ClinicalTrials.gov study NCT03044743. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT)
ClinicalTrials.gov study NCT04105335. IPD Sharing: NO. Countries: 1. Publications: 2.
Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma
ClinicalTrials.gov study NCT05595265. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours
ClinicalTrials.gov study NCT06697665. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT07138989. IPD Sharing: NO. Countries: 1. Publications: 4.
Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
ClinicalTrials.gov study NCT06084897. IPD Sharing: YES. Countries: 1. Publications: 3.
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
ClinicalTrials.gov study NCT04116320. IPD Sharing: YES. Countries: 1. Publications: 1.
Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center
ClinicalTrials.gov study NCT06108596. IPD Sharing: NO. Countries: 1. Publications: 0.
Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)
ClinicalTrials.gov study NCT05587374. IPD Sharing: NO. Countries: 1. Publications: 4.
Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC
ClinicalTrials.gov study NCT03044626. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
ClinicalTrials.gov study NCT02636036. IPD Sharing: NO. Countries: 1. Publications: 2.
Neoadjuvant PD-1 Monoclonal Antibody in Cisplatin-ineligible High Risk Upper Tract Urothelial Carcinoma
ClinicalTrials.gov study NCT04672330. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer
ClinicalTrials.gov study NCT04250948. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma
ClinicalTrials.gov study NCT04799548. IPD Sharing: NO. Countries: 1. Publications: 6.
PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery
ClinicalTrials.gov study NCT04295317. IPD Sharing: NO. Countries: 1. Publications: 1.
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06865339. IPD Sharing: NO. Countries: 1. Publications: 37.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.